M's Science Corporation – Product Pipeline Review – Q4 2010

Date: November 1, 2010
Pages: 23
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: MB99AEAD1D8EN
Leaflet:

Download PDF Leaflet

M's Science Corporation – Product Pipeline Review – Q4 2010
M's Science Corporation – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “M's Science Corporation – Product Pipeline Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • M's Science Corporation – Brief company overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of M's Science Corporation human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of M's Science Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the M's Science Corporation’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy
  • Evaluate M's Science Corporation’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of M's Science Corporation in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the M's Science Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with M's Science Corporation.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of M's Science Corporation and identify potential opportunities in those areas.
M's Science Corporation Snapshot
M's Science Corporation Overview
Key Information
Key Facts
M's Science Corporation – Research and Development Overview
Key Therapeutic Areas
M's Science Corporation – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
M's Science Corporation – Pipeline Products Glance
M's Science Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
M's Science Corporation–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
M's Science Corporation – Drug Profiles
SA4503
  Product Description
  Mechanism of Action
  R&D Progress
MC116
  Product Description
  Mechanism of Action
  R&D Progress
MC113
  Product Description
  Mechanism of Action
  R&D Progress
M's Science Corporation – Pipeline Analysis
M's Science Corporation – Pipeline Products by Therapeutic Class
M's Science Corporation Pipeline Products By Target
M's Science Corporation – Pipeline Products by Route of Administration
M's Science Corporation – Locations And Subsidiaries
Head Office
Recent Developments
Mar 12, 2008: M's Science And Eisai Sign Option Agreement For Sigma Agonist SA4503
Jan 30, 2008: M's Science Corporation Initiated European Phase II Study In Stroke Recovery
Aug 27, 2007: M's Science Corporation Initiated Phase II study In Major Depression In Europe
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

M's Science Corporation – Pipeline by Therapy Area and Indication, 2010
M's Science Corporation – Pipeline by Stage of Development, 2010
M's Science Corporation – Monotherapy Products in Pipeline, 2010
M's Science Corporation - Phase II, 2010
M's Science Corporation - Pipeline By Therapeutic Class, 2010
M's Science Corporation - Pipeline By Target, 2010
M's Science Corporation – Pipeline By Route of Administration, 2010 18

LIST OF FIGURES

M's Science Corporation – Pipeline by Therapy Area and Indication, 2010
M's Science Corporation – Pipeline by Stage of Development, 2010
M's Science Corporation – Monotherapy Products in Pipeline, 2010
M's Science Corporation – Pipeline By Therapeutic Class, 2010
M's Science Corporation - Pipeline By Target, 2010 17

Ask Your Question

M's Science Corporation – Product Pipeline Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: